A biotech agency based by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease remedy that Pfizer gave it at no cost
Conservative entrepreneur Vivek RamaswamyScott Olson/Getty Pictures Roche acquired a bowel-disease remedy from Roivant for over $7 billion, the Wall Avenue Journal reported. Roivant made $5 billion from the sale, after…